Literature DB >> 25887160

Sexual dimorphism of lipid metabolism in very long-chain acyl-CoA dehydrogenase deficient (VLCAD-/-) mice in response to medium-chain triglycerides (MCT).

Sara Tucci1, Ulrich Flögel2, Ute Spiekerkoetter3.   

Abstract

Medium-chain triglycerides (MCT) are widely applied in the treatment of long-chain fatty acid oxidation disorders. Previously it was shown that long-term MCT supplementation strongly affects lipid metabolism in mice. We here investigate sex-specific effects in mice with very-long-chain-acyl-CoA dehydrogenase (VLCAD) deficiency in response to a long-term MCT modified diet. We quantified blood lipids, acylcarnitines, glucose, insulin and free fatty acids, as well as tissue triglycerides in the liver and skeletal muscle under a control and an MCT diet over 1 year. In addition, visceral and hepatic fat content and muscular intramyocellular lipids (IMCL) were assessed by in vivo(1)H magnetic resonance spectroscopy (MRS) techniques. The long-term application of an MCT diet induced a marked alteration of glucose homeostasis. However, only VLCAD-/- female mice developed a severe metabolic syndrome characterized by marked insulin resistance, dyslipidemia, severe hepatic and visceral steatosis, whereas VLCAD-/- males seemed to be protected and only presented with milder insulin resistance. Moreover, the highly saturated MCT diet is associated with a decreased hepatic stearoyl-CoA desaturase 1 (SCD1) activity in females aggravating the harmful effects of a saturated MCT diet. Long-term MCT supplementation deeply affects lipid metabolism in a sexual dimorphic manner resulting in a severe metabolic syndrome only in female mice. These findings are striking since the first signs of insulin resistance already occur in female VLCAD-/- mice during their reproductive period. How these metabolic adaptations are finally regulated needs to be determined. More important, the relevance of these findings for humans under these dietary modifications needs to be investigated.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  MCT supplementation; Metabolic syndrome; Sexual dimorphism; VLCAD-deficiency

Mesh:

Substances:

Year:  2015        PMID: 25887160     DOI: 10.1016/j.bbadis.2015.04.009

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  6 in total

1.  Slc22a5 haploinsufficiency does not aggravate the phenotype of the long-chain acyl-CoA dehydrogenase KO mouse.

Authors:  Pablo Ranea-Robles; Chunli Yu; Naomi van Vlies; Frédéric M Vaz; Sander M Houten
Journal:  J Inherit Metab Dis       Date:  2019-12-23       Impact factor: 4.982

2.  Triheptanoin: long-term effects in the very long-chain acyl-CoA dehydrogenase-deficient mouse.

Authors:  Sara Tucci; Ulrich Floegel; Frauke Beermann; Sidney Behringer; Ute Spiekerkoetter
Journal:  J Lipid Res       Date:  2016-11-24       Impact factor: 5.922

Review 3.  Very long-chain acyl-CoA dehydrogenase (VLCAD-) deficiency-studies on treatment effects and long-term outcomes in mouse models.

Authors:  Sara Tucci
Journal:  J Inherit Metab Dis       Date:  2017-02-28       Impact factor: 4.982

4.  TransOmic analysis of forebrain sections in Sp2 conditional knockout embryonic mice using IR-MALDESI imaging of lipids and LC-MS/MS label-free proteomics.

Authors:  Philip Loziuk; Florian Meier; Caroline Johnson; H Troy Ghashghaei; David C Muddiman
Journal:  Anal Bioanal Chem       Date:  2016-03-04       Impact factor: 4.142

5.  Sexual Dimorphism in Energy Metabolism of Wistar Rats Using Data Analysis.

Authors:  Andrea Leskanicova; Olga Chovancova; Marian Babincak; Ludmila Verboova; Zuzana Benetinova; Denisa Macekova; Jozef Kostolny; Benadik Smajda; Terezia Kiskova
Journal:  Molecules       Date:  2020-05-18       Impact factor: 4.411

6.  Targeted metabolomic profiling in rat tissues reveals sex differences.

Authors:  Margherita Ruoppolo; Marianna Caterino; Lucia Albano; Rita Pecce; Maria Grazia Di Girolamo; Daniela Crisci; Michele Costanzo; Luigi Milella; Flavia Franconi; Ilaria Campesi
Journal:  Sci Rep       Date:  2018-03-16       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.